Literature DB >> 8648546

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.

M M Mustafa1, V M Aquino, A Pappo, I Tkaczewski, G R Buchanan.   

Abstract

Febrile neutropenic children with cancer were eligible for outpatient management with intravenous ceftriaxone therapy if they displayed selected low-risk criteria. Nineteen children were enrolled. All patients had sterile blood cultures, and only one of them was hospitalized because of persistent fever. This pilot study suggests that selected children with febrile neutropenia might be successfully managed without hospitalization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648546     DOI: 10.1016/s0022-3476(96)70339-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.

Authors:  A Manji; J Beyene; L L Dupuis; R Phillips; T Lehrnbecher; L Sung
Journal:  Support Care Cancer       Date:  2012-03-09       Impact factor: 3.603

2.  Feasibility of integrated home/hospital physiotherapeutic support for children with cancer.

Authors:  Christian Savio; Alberto Garaventa; Marina Gremmo; Riccardo Camoriano; Luca Manfredini; Sara Fieramosca; Giorgio Dini; Maurizio Miano
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

3.  [Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].

Authors:  Sandra Gala Peralta; Teresa Cardesa Salzman; Juan José García García; Jesús Estella Aguado; Amadeu Gené Giralt; Carles Luaces Cubells
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

4.  Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.

Authors:  Rodolfo Rivas-Ruiz; Miguel Villasis-Keever; Guadalupe Miranda-Novales; Osvaldo D Castelán-Martínez; Silvia Rivas-Contreras
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

Review 5.  Outpatient therapy for febrile neutropenia: clinical and economic implications.

Authors:  Fausto de Lalla
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.

Authors:  D Nathwani
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 7.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 8.  Outpatient management of febrile neutropenia in children with cancer.

Authors:  Mark Holdsworth; Jeff Hanrahan; Bernadette Albanese; Jami Frost
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Authors:  Jeremy Rosenblum; Juan Lin; Mimi Kim; Adam S Levy
Journal:  Pediatr Blood Cancer       Date:  2012-10-09       Impact factor: 3.167

10.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.